Software Engineering Intern, Deep Genomics

May to December 2024

Salary not provided

React

Docker

TypeScript

JavaScript

Python

Firestore

Git

REST API

Toronto

AI powered RNA therapy discovery

Job no longer available

AI powered RNA therapy discovery

101-200 employees

HealthcareB2BArtificial IntelligenceBiologyMedTech

Job no longer available

Salary not provided

React

Docker

TypeScript

JavaScript

Python

Firestore

Git

REST API

Toronto

101-200 employees

HealthcareB2BArtificial IntelligenceBiologyMedTech

Company mission

To untangle the complexity in RNA biology, and evaluates thousands of possibilities to identify the best therapeutic candidates.

Job

Company

Role

Who you are

Solid knowledge of JavaScript and React; previous experience with TypeScript is an asset but is not required
Some previous experience using Python to create REST APIs for web services
Solid understanding of Git/GitHub and branch-based workflows
Prior experience building automated tests for front-end applications is desirable but not required
Prior experience with Docker and continuous integration tools such as CircleCI is desirable but not required

What the job involves

You’d work alongside experienced software engineers to build tools and services for the internal platform that handles analysis and ingestion of raw data from various lab experiments
This platform uses TypeScript and React on the front end, Python on the back end, and a mixture of PostgreSQL, Firestore, and Google Cloud Storage for data storage
While the position will focus on front-end development, we expect the successful candidate to be involved in all layers of the application

Our take

Deep Genomics uses AI to analyze genetic data with the aim of discovering and producing RNA-based genetic medicines. The company is currently running a series of programs with the aim of advancing to clinical trials in the near future.

RNA medical technology has been in development for over 40 years but never became mainstream, but the launch of BioNTech/Pfizer’s Covid-19 vaccine threw it into the public spotlight. And this is set to accelerate the production of more and more RNA-based therapeutics, supplemented by AI which can quickly mine dense biological data to better evaluate potential candidates.

With its financial backing in the hundreds of millions, Deep Genomics now intends to radically boost its headcount and roll out more therapeutic discovery programs.

Kirsty

Company Specialist at Welcome to the Jungle

Insights

Top investors

-22% employee growth in 12 months

Glassdoor (3.4)

Company

Funding (last 2 of 4 rounds)

Jul 2021

$180m

SERIES C

Jan 2020

$40m

SERIES B

Total funding: $236.8m

Company HQ

Discovery District, Toronto, ON

Leadership

Brendan Frey, Ph.D.

(Founder, CIO & Board Member)

Professor of Engineering and Medicine at the University of Toronto. Co-founded the Vector Institute for Artificial Intelligence. They have carried out pioneering work in the fields of deep learning, genomic medicine, and information technology.

Brian O'Callaghan

(CEO & Board Member)

Brian is an experienced CEO having previously served at ObsEva, Petra Pharma Corporation, Sonrgy, Acucela, and Sangart.

Salary benchmarks

We don't have enough data yet to provide salary benchmarks for this role.

Submit your salary to help other candidates with crowdsourced salary estimates.

Share this job

View 1 more job at Deep Genomics